GLOBAL RESEARCH ARCHIVE
IR Meeting Following T&D Financial Takeover
Research evidence excerpt
IR Meeting Following T&D Financial Takeover
Japan | Payments, Processors & IT Services
PayPay EquityJuneResearch9, 2026
FLASH NOTEIR Meeting Following T&D Financial Takeover
We held a meeting with the IR team following the announcement of the RATING BUY
70.2% takeover of T&D Financial (meeting was already planned). The key PRICE $15.17^
point is that the company wanted majority control of an insurance company PRICE TARGET | % TO PT $28.00 | +85%
instead of partial control, so that it can focus on strategy and product 52W HIGH-LOW $24.89 - $14.97
innovation in future, which we believe is sensible. Therefore, the success FLOAT (%) | ADV MM (USD) 98.3% | 13.89
will come from cross-selling and post merger integration (PMI) synergy MARKET CAP $10.3B
potential of the new company. TICKER PAYP
^Prior trading day's closing price unless otherwise
noted.
Rationale for the Transaction: In order to become a multi-service fintech company, PayPay
needed to acquire an insurance company. Majority control of the company is important, as
management can control strategy and product development of the new company, rather than
partnership. In addition, acquiring the Japanese insurance license is also important from this
acquisition. The Price to Embedded Value (PEV) is approximately 1x, which the company
believes is not too expensive. Potential synergies will come from cross-selling insurance to the
74mn PayPay registered users and improving investment returns from partnership with other
equity holders in One Investment Ltd. PayPay raised roughly ¥100bn from the IPO and will use
cash and retained earnings to cover the ¥134bn transaction.
Going Forward: The expected completion of the deal is Oct 2027. In order to archive
integration, TDF financials have to be converted into IFRS.
The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.
Open report viewer